載入中
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
前收盤價
US$27.28
+US$0.89 · +3.37%
盤中時間採用ET。市場資料可能有所延遲。
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
日內區間
目前US$27.28
52週區間
目前US$27.28
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 2.56億 USD | 2.08億 USD | 2.17億 USD | 1.81億 USD | 1.38億 USD |
| 銷貨成本 | 1.13億 USD | 7545.6萬 USD | 7597.4萬 USD | 7993.3萬 USD | 7231.1萬 USD |
| 毛利 | 1.43億 USD | 1.32億 USD | 1.41億 USD | 1.01億 USD | 6562萬 USD |
| 研究與開發 | 1.73億 USD | 2.02億 USD | 1.82億 USD | 1.26億 USD | 9090.4萬 USD |
| 銷售、一般及管理費用 | 1.36億 USD | 1.4億 USD | 1.36億 USD | 1.21億 USD | 8615.9萬 USD |
| 營業費用 | 3.1億 USD | 3.41億 USD | 3.18億 USD | 2.48億 USD | 1.77億 USD |
| 利息收入 | — | — | — | 395萬 USD | 105.7萬 USD |
| 利息支出 | — | — | — | 3000 USD | — |
| 折舊和攤銷 | 602.2萬 USD | 615.9萬 USD | 555.2萬 USD | 434.4萬 USD | 284.7萬 USD |
| 營業利益 | −1.67億 USD | −2.09億 USD | −1.77億 USD | −1.47億 USD | −1.11億 USD |
| 淨利 | −1.03億 USD | −1.87億 USD | 4072萬 USD | −1.49億 USD | −1億 USD |
公司資料更新於 2026年10月11日。
第三方分析師預期可能變動，並非 GoAI 建議。
報告持有此股票曝險的交易所交易基金。
ARK Genomic Revolution ETFARKG5925.86萬2.89%15.57億 USD0.75%US$51.30+4.08%
iShares Russell 2000 ETFIWM4041.25萬0.05%787.4億 USD0.19%US$278.94+0.49%
Vanguard Morningstar Total Stock Market ETFVTI3831.88萬0.00%2.3兆 USD0.03%US$381.94+0.63%
Vanguard Morningstar Small-Cap ETFVB2785.67萬0.01%1853億 USD0.03%US$289.48+0.64%
Vanguard Morningstar Small-Cap Growth ETFVBK1600.65萬0.04%447億 USD0.05%US$344.74+1.22%
iShares Russell 2000 Growth ETFIWO1410.03萬0.10%139.17億 USD0.24%US$356.78+0.94%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM1389.78萬0.09%158.4億 USD0.03%US$53.45+0.17%
Vanguard Extended Market ETFVXF1295.4萬0.01%954億 USD0.05%US$235+0.80%ARK Genomic Revolution ETFARKGiShares Russell 2000 ETFIWMVanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Growth ETFVBKiShares Russell 2000 Growth ETFIWOState Street SPDR Portfolio S&P 600 Small Cap ETFSPSMVanguard Extended Market ETFVXFAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
